The University of Chicago Header Logo

Connection

Neval Ozkaya to Histiocytosis

Back to Details
This is a "connection" page, showing publications Neval Ozkaya has written about Histiocytosis.
Neval Ozkaya
Connection Strength
0.361
Histiocytosis
  1. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019 03; 567(7749):521-524.
    View in: PubMed
    Score: 0.168
  2. Single-agent dabrafenib for BRAFV600E-mutated histiocytosis. Haematologica. 2018 04; 103(4):e177-e180.
    View in: PubMed
    Score: 0.156
  3. A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Nature. 2017 09 21; 549(7672):389-393.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.